Cansino Biologics Stock Net Income

688185 Stock   61.23  0.13  0.21%   
Cansino Biologics fundamentals help investors to digest information that contributes to Cansino Biologics' financial success or failures. It also enables traders to predict the movement of Cansino Stock. The fundamental analysis module provides a way to measure Cansino Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cansino Biologics stock.
Last ReportedProjected for Next Year
Net Loss-2 B-1.9 B
Net Loss-1 B-993.6 M
Net Loss-1.4 B-1.4 B
The current year's Net Loss is expected to grow to about (1.9 B). The current year's Net Loss is expected to grow to about (993.6 M).
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cansino Biologics Company Net Income Analysis

Cansino Biologics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Cansino Biologics Net Income

    
  (1.45 B)  
Most of Cansino Biologics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cansino Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Cansino Net Interest Income

Net Interest Income

27.11 Million

At present, Cansino Biologics' Net Interest Income is projected to increase significantly based on the last few years of reporting.
Based on the recorded statements, Cansino Biologics reported net income of (1.45 Billion). This is 524.08% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all China stocks is significantly higher than that of the company.

Cansino Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cansino Biologics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cansino Biologics could also be used in its relative valuation, which is a method of valuing Cansino Biologics by comparing valuation metrics of similar companies.
Cansino Biologics is currently under evaluation in net income category among its peers.

Cansino Fundamentals

About Cansino Biologics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cansino Biologics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cansino Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cansino Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Cansino Stock

Cansino Biologics financial ratios help investors to determine whether Cansino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansino with respect to the benefits of owning Cansino Biologics security.